Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

China · Delayed Price · Currency is CNY

4.010

+0.090 (2.30%)

Jul 1, 2026, 2:45 PM CST

-8.45% (1Y)

Market Cap	9.94B -13.3%
Revenue (ttm)	6.69B +5.0%
Net Income	483.42M -18.9%
EPS	0.19 -16.1%
Shares Out	2.54B
PE Ratio	20.28
Forward PE	n/a
Dividend	0.15 (3.76%)
Ex-Dividend Date	Jun 24, 2026

Volume	33,424,031
Open	3.900
Previous Close	3.920
Day's Range	3.870 - 4.030
52-Week Range	3.770 - 5.170
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1969

Employees 7,826

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600572

Full Company Profile

Financial Performance

In 2025, SHA:600572's revenue was 6.47 billion, a decrease of -0.64% compared to the previous year's 6.52 billion. Earnings were 474.36 million, a decrease of -23.79%.

Financial Statements